Stem Cells - A Hard Sell to Investors  

Oleh:

Giebel, Lutz B.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 7 (Jul. 2005), page 798-800.
Topik: STEM CELL; stem cells; investors

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.3 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

A lack of proven commercial success and a surfeit of ethical, legal and political problems make stem cell companise a difficult pitch to venture capaitalists. Human degenerative disease present a large unmet medical need, and the market potential for successful therapies is great. For many degenerative disease where large numbers of functional cells have been irreversible destroyed, it is difficult to imagine how small molecule drugs or even recombinant proteins would be able to reverse the damage and restore function. Stem cells, whether adult or embryonic provide a source from which fully differentiate, functional cells could be derived.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali